Safety and quality update: September 2021

21 September 2021

New this month: Updated Delirium Clinical Care Standard, National Sepsis Awareness Campaign, and National Medicines Policy (NMP) Review

Safety alerts

For all safety alerts see here.

Launch of updated Delirium Clinical Care Standard, 2021

The updated Delirium Clinical Care Standard was launched at the Australasian Delirium Association Conference, DECLARED 2021, on Thursday 9 September 2021, by Associate Professor Gideon Caplan, President of the Australasian Delirium Association.

Professor Susan Kurrle, geriatrician and Curran Chair in Health Care of Older People in the Faculty of Medicine and Health at the University of Sydney and Anne Cumming, Principal Advisor, Cognitive Impairment at the Commission, presented about the Delirium Clinical Care Standard and updates, followed by a panel discussion with Dr Carolyn Hullick, Clinical Director from the Australian Commission on Safety and Quality in Health Care and emergency physician. These presentations will be available here after the conference.

National Sepsis Awareness Campaign

A dedicated sepsis awareness campaign landing page has been launch by the Australian Commission on Safety and Quality in Health Care which houses both the campaign toolkit and media toolkit. Print-ready resources are accessible at the campaign landing page for health service organisations and state and territory representatives conducting local campaign activities.
The Commission encourages health service organisations and state and territory representatives to support increased sepsis awareness through participation in the campaign.

Visit the campaign landing page for more information and ways you can get involved.

National Medicines Policy (NMP) Review

The Review of the NMP has been commissioned by the Minister for Health, the Hon. Greg Hunt MP in recognition of the substantial changes to the health landscape since the policy was published in 2000.

Australia’s National Medicines Policy (NMP) aims to deliver positive health outcomes for all Australians through their access to and appropriate use of medicines. It is a well-established and universally endorsed framework based on partnerships between consumers and all segments of the medicines sector to promote the NMP’s four central objectives.

Stakeholders are invited to participate in the consultation by responding to the questions within the Discussion Paper via the Consultation Survey. Consultation is now open and will close on Friday 8 October 2021. Visit the NMP Review page for more information.

Last updated 10:37 21.09.2021